PURPOSE:Through its global and extensive connections with multiple brain structures, the thalamus can play an important role in seizure propagation. This study investigated volumetric and functional connectivity alterations of the thalamus and more specifically the thalamic nuclei subgroups using 7T MRI in patients with MRI-negative drug-resistant focal epilepsy (DRE). METHODS:Twenty-nine patients with MRI-negative DRE and 49 healthy controls underwent 7T MRI, including T1-weighted and resting-state functional MRI sequences. Thalamic nuclei segmentations were derived using automated segmentation tools and split into anterior (ANT), medial, ventral, and posterior nuclei groups. Functional connectivity with the rest of the brain was assessed using degree centrality (DC). Linear regression models evaluated group differences and relationships with epilepsy characteristics while controlling for age and sex. Asymmetry indices assessed the ipsi- vs. contralateral differences in the patient cohort. RESULTS:Patients showed decreased bilateral medial and increased bilateral ventral relative volumes, alongside a right-sided ANT volume increase, compared with controls. DC was increased in the left posterior and ventral nuclei. Both volume and DC in the medial, ventral, and whole-thalamic ROIs were related to epilepsy duration, while ventral and whole-thalamic DC asymmetry distinguished patients by seizure type and seizure duration. CONCLUSIONS:Both structural and functional alterations of the thalamic nuclei groups in patients with DRE were observed. Ventral, medial, and posterior nuclei metrics show promise as imaging biomarkers of disease burden and seizure severity, thus encouraging further research into both structural and functional properties of thalamic nuclei in focal epilepsy.
Speech brain-computer interfaces (BCIs) offer a solution for those affected by speech impairments by decoding brain activity into speech. Current neuroprosthetics focus on the motor cortex, which might not be suitable for all patient populations. We investigate potential alternative targets for a speech BCI across a brain-wide distribution. Thirty participants are recorded with intracranial electroencephalography during speech production. We continuously predict speech from a brain-wide global to a single-channel local scale, across anatomical features. We find significant speech detection accuracy in both gray and white matter, no significant difference between gyri and sulci, and limited contribution from subcortical areas. Potential targets are located within the depths of and surrounding the lateral fissure bilaterally, such as the (sub)central sulcus, the transverse temporal gyrus, the supramarginal cortex, and parts of the insula. The results highlight the potential benefit of extending beyond the motor cortical surface and reaching the sulcal depth for speech neuroprostheses.
This paper provides an overview of the domain challenges, use cases, objectives, high-level concepts, intended innovations, and expected impact of the DistriMuSe project. The project’s main aim is to enhance human health and safety by improved sensing of human presence, behaviour, intentions and vital signs in a collaborative or common environment by means of multi-sensor systems, distributed processing and machine learning. The use cases address challenges in health monitoring of elderly, sleep and exercise, of drivers and vulnerable road users in traffic and of people interacting with robots in a factory environment. Technical development in the project focuses on unobtrusive monitoring sensors, multi-sensor systems, distribution of computation and intelligence, and domain specific needs for the use cases.
Atrial fibrillation (AF) is often associated with obstructive sleep apnea (OSA). Several OSA mechanisms might lead to AF onset, including intrathoracic pressure shifts, sympatho-vagal imbalance and hypoxemia. A better understanding of the relevant pathophysiologic mechanisms might lead to better risk stratification of patients with AF and OSA, since the necessity of diagnosing and treating OSA as upstream therapy for AF remains to divide the cardiologic community. This study aimed to clarify the role of acute mechanisms of OSA in the onset of AF during sleep. This could ruther elucidate in which patient with OSA and AF, OSA is a relevant proarrhythmogenic factor and in which it is merely a bystander. We conducted a prospective observational study with a polysomnography (PSG). A case-crossover design was employed to analyse AF onsets, comparing a 90-second hazard period preceding AF onset with control periods, matched for sleep stage, within the same patient. Control periods were selected using a backward moving window approach, starting five minutes prior to the onset of AF. We assessed heart rate variability using root mean square standard deviation (RMSSD) as a surrogate for sympatho-vagal tone, respiratory inductance plethysmography belts as surrogate for intrathoracic pressure and hypoxic burden. A linear mixed model was used to compare hazard and control periods, incorporating random effects to account for variability between patients and between hazard and control periods. We corrected for age, sex, left atrial volume and body mass index. Sensitivity analyses were performed to validate the results across extended control periods. A total of 198 patients were eligible for participation of which 158 were referred for PSG. Forty patients declined referral to a sleep medicine clinic. Of the remaining 158 patients, 155 were diagnosed with OSA. Among the 155 patients analysed, 19 patients had 45 usable onsets of AF. Non-usable onsets were onsets <5 minutes after termination of AF or occurring during wakefulness. RMSSD was significantly higher during hazard periods compared to control periods (estimate 0.599, p = 0.003), indicating enhanced vagal tone prior to AF onset. Heart rate, relative respiratory effort, and hypoxic burden did not differ significantly between these periods. The findings were consistent in sensitivity analysis, with RMSSD remaining significant (p = 0.002). Our study highlights that increased vagal tone, as reflected by elevated RMSSD, is a predominant mechanism in the acute onset of AF among patients with OSA. Hypoxemia and respiratory effort did not show significant variations. These results suggest that RMSSD could serve as a potential clinical marker for identifying patients who may benefit from targeted OSA treatment in rhythm control strategies for AF. Future research should aim at identifying a pro-arrhythmogenic OSA phenotype for improved patient selection.Patient characteristics per subgroup Parameter estimation OSA mechanisms